NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
04/29/2025
Back to search
Official data from USPTO
THÉRAPRÉVAX SAINT-LOUIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/30/2025
Trademark type
Combined
Nice classes
42
Filing date
08/23/2021
Registration date
03/21/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/21/2023
Last transaction
04/30/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/23/2021
First use in commerce
07/23/2021
Drawing code
3
Owner type
16
Owner location
Clayton, MO
Examiner
FALK,JONATHAN ROBERT
Current location
Historical data usage
Mark description
The mark consists of four fleur-de-lis shapes arranged symmetrically and mirrored with each other to the left of the wording THÉRAPRÉVAX above SAINT-LOUIS all in yellow (hex# ffed2a) on a blue (hex# 000099) background.
Holders and representatives
Holders
Théraprévax, LLC
Representatives
Théraprévax, LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Vaccine research and development
Publications
History of USPTO decisions and trademark events.
30 publications found
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
11/14/2024
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
10/18/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
10/03/2024
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
07/09/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/18/2024
ES7R
TEAS SECTION 7 REQUEST RECEIVED
11/12/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
03/21/2023
CHPB
POST PUBLICATION AMENDMENT - ENTERED
01/10/2023
APET
ASSIGNED TO PETITION STAFF
01/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/03/2023
PUBO
PUBLISHED FOR OPPOSITION
01/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/14/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
12/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/30/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
11/30/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/30/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
11/30/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/30/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/26/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/25/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/07/2022
GNRT
NON-FINAL ACTION E-MAILED
06/07/2022
CNRT
NON-FINAL ACTION WRITTEN
06/07/2022
DOCK
ASSIGNED TO EXAMINER
05/24/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/08/2021
NWAP
NEW APPLICATION ENTERED
08/26/2021
Continuous trademark protection
Get notified about every new filing that threatens THÉRAPRÉVAX SAINT-LOUIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.